Semantix Announces 3Q 2023 Financial Results
SÃO PAULO,
"We're excited to report another quarter of substantial year-over-year growth in our proprietary SaaS offerings, primarily driven by the success of our AI applications, especially within the specific industry sectors we've prioritized. We continue to see promising growth opportunities in these areas," shared
Third Quarter 2023 Financial Highlights
- Proprietary SaaS revenue for the third quarter of 2023 grew 41% year-over-year.
- Gross margin improved 14 percentage points year-over-year to 62% in the third quarter of 2023, reflecting the higher share of Proprietary SaaS in
Semantix's revenue mix. - Net revenue for the third quarter of 2023 of
R$40 million , reflecting a decrease of 51% year-over-year as compared to the third quarter of 2022. Semantix had 10 customers in the third quarter of 2023 each contributing more thanUS$1 million in revenue in the last twelve months.- Adjusted EBITDA loss in the third quarter of 2023 was
R$17 million . Cash and cash equivalents ofR$111 million as ofSeptember 30, 2023 . Net cash (net of the loans and borrowings) wasR$57 million as ofSeptember 30, 2023 .
Key Business Highlights
- Cash Management and Enhanced Efficiency:
Semantix has proactively identified new avenues to reduce cash outflows, achieving a remarkable reduction of over 30% in annualized costs1 and expenses, as compared toJune 2023 . As a result,Semantix expects to achieve operational cash break-even status by 2024.
1 – do not consider Resale of
- Product Development:
Semantix has introduced an advanced integrated solution for the retail industry. The first module, already available, is meticulously crafted to elevate the customer journey by gathering and analyzing data from e-commerce and digital marketing channels. This, in turn, empowers retailers to enhance the overall shopping experience. Importantly, this product finds its strategic placement within those retailers who have already a data integration solution in place. Moreover, this comprehensive solution provides retailers with actionable intelligence derived from their data, granting them a competitive advantage in comprehending customer behavior and staying attuned to emerging market trends.Semantix introduced ChatPharma, a cutting-edge application that empowers pharmaceutical industry executives to querySemantix's unique health data set by using generative AI, facilitating rapid access to insights, including tables and charts developed by GenAI.Semantix has successfully integrated four AI algorithms into its health applications within hospital operations. These algorithms were implemented during the third quarter and have significantly improved the competitiveness ofSemantix's products while maintaining minimal cost impact.Semantix has extended itsGenAI Hub offering by incorporating multiple LLMs, reinforcing its truly multi-generative AI nature. The company now features specialized LLM models for a diverse range of tasks, from source code generation to natural language understanding and inference, among others. By synergizing these models,Semantix can create agents that harness the strengths of each LLM available. Beyond its appeal toSemantix's customers, the GenAI Hub also streamlines the development ofSemantix's AI applications. Semantix’s GenAI hub creates an abstraction layer for companies to apply GenAI within their own infrastructure in a much simpler and secure way. The company is currently involved in numerous application development and testing initiatives in collaboration with its valued clients.
3Q23 Financial Metrics
(In BRL million, except for percentages)
3Q 2023 | 3Q 2022 | Y/Y Change |
9M 2023 | 9M 2022 | Y/Y Change |
|||||||
Net Revenue | (51 | )% | (23 | )% | ||||||||
Gross Profit | (36 | )% | (4 | )% | ||||||||
Gross Margin | 62 | % | 48 | % | 14 pp | 50 | % | 40 | % | 10 pp | ||
Loss for the period | (86 | )% | (62 | )% | ||||||||
Adjusted EBITDA | 183 | % | 79 | % | ||||||||
Adjusted EBITDA Margin | (43 | )% | (8 | )% | (35 pp) | (59 | )% | (25 | )% | (34 pp) |
Change | ||||
Cash and Cash Equivalents | (67 | )% | ||
(78 | )% |
Financial Outlook
Conference Call and Webcast Information
Forward-Looking Statements
This report on form 6-K (“6-K”) contain forward-looking statements and forward-looking information within the meaning of applicable
Such forward-looking statements are based on the current expectations of our management and are inherently subject to uncertainties and changes in circumstance and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements and could adversely affect the outcome and financial effects of the plans and events described herein. In addition, even if the outcome and financial effects of the plans and events described herein are consistent with the forward-looking statements contained in this 6-K, those results or developments may not be indicative of results or developments in subsequent periods. Although
Nothing in this 6-K should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this 6-K, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. This 6-K also contains certain financial forecast information of
WE DO NOT UNDERTAKE ANY OBLIGATION AND EXPRESSLY DISCLAIM ANY RESPONSIBILITY TO UPDATE OR REVISE, OR PUBLICLY DISCLOSE ANY UPDATE OR REVISION TO, ANY FINANCIAL FORECASTS CONTAINED HEREIN TO REFLECT CIRCUMSTANCES OR EVENTS, INCLUDING UNANTICIPATED EVENTS, THAT MAY HAVE OCCURRED OR THAT MAY OCCUR AFTER THE PREPARATION OF THESE FORECASTS. HOWEVER, WE MAY ELECT TO UPDATE OUR BUSINESS OUTLOOK AT ANY TIME FOR ANY REASON.
Non-GAAP Financial Measures
This 6-K includes certain non-IFRS financial measures and industry metrics such as EBITDA, EBITDA margin, Adjusted EBITDA, Adjusted EBITDA margin and net cash (debt). These measures are an addition, and not a substitute for or superior to, measures of financial performance prepared in accordance with IFRS and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with IFRS.
Other Business Metrics
Proprietary SaaS and Resale of
Customers with Trailing 12-Month Revenue Greater than
Unaudited Consolidated Statement of Profit or Loss
(in BRL thousands)
Three Months Ended, |
Nine Months Ended, |
|||||||
2023 | 2022 | 2023 | 2022 | |||||
Revenues | 40,041 | 80,638 | 127,723 | 166,180 | ||||
Cost of sales | (15,214 | ) | (41,563 | ) | (63,365 | ) | (99,356 | ) |
Gross profit | 24,827 | 39,075 | 64,358 | 66,824 | ||||
Operating expenses | ||||||||
Sales and marketing expenses | (12,203 | ) | (13,466 | ) | (39,407 | ) | (38,296 | ) |
General and administrative expenses | (29,788 | ) | (37,359 | ) | (106,091 | ) | (64,278 | ) |
Research and development | (13,370 | ) | (4,127 | ) | (34,692 | ) | (24,692 | ) |
Listing expenses and Others | — | (198,733 | ) | — | (231,312 | ) | ||
Operating loss | (30,534 | ) | (214,610 | ) | (115,832 | ) | (291,754 | ) |
Financial income | 4,434 | 23,272 | 24,284 | 29,902 | ||||
Financial expenses | (2,669 | ) | (12,284 | ) | (20,833 | ) | (31,492 | ) |
Net financial results | 1,765 | 10,988 | 3,451 | (1,590 | ) | |||
Loss before income tax | (28,769 | ) | (203,622 | ) | (112,381 | ) | (293,344 | ) |
Income tax | 358 | 4,102 | 112 | 7,674 | ||||
Loss for the period | (28,411 | ) | (199,520 | ) | (112,269 | ) | (285,670 | ) |
Unaudited Revenue Mix
(in BRL thousands)
Three Months Ended, |
Nine Months Ended, |
|||||||
2023 | 2022 | 2023 | 2022 | |||||
Third-party software | 21,321 | 64,363 | 71,791 | 116,609 | ||||
Deductions on third-party software | (2,573 | ) | (7,243 | ) | (7,917 | ) | (12,186 | ) |
Revenue from Third-party software | 18,748 | 57,120 | 63,874 | 104,423 | ||||
AI & data analytics services | 6,827 | 13,998 | 24,658 | 33,074 | ||||
Deductions on AI & data analytics services | (459 | ) | (987 | ) | (1,653 | ) | (2,237 | ) |
Revenue from AI & data analytics services | 6,368 | 13,011 | 23,005 | 30,837 | ||||
Proprietary software as a service (SaaS) | 15,925 | 11,192 | 43,425 | 33,031 | ||||
Deductions on proprietary software as a service (SaaS) | (1,151 | ) | (685 | ) | (3,044 | ) | (2,114 | ) |
Revenue from proprietary software as a service (SaaS) | 14,774 | 10,507 | 40,381 | 30,917 | ||||
Other revenue | 151 | — | 463 | 3 | ||||
Total revenue | 40,041 | 80,638 | 127,723 | 166,180 |
Unaudited Consolidated Statement of Cash Flows
(in BRL thousands)
Nine months ended |
||||
2023 | 2022 | |||
Loss for the period | (112,269 | ) | (285,670 | ) |
Adjustments to reconcile loss for the period | 26,630 | 219,450 | ||
Depreciation and amortization of property and equipment and right-of-use assets and intangible assets | 23,755 | 12,324 | ||
Onerous contract | (5,274 | ) | (7,772 | ) |
(Reversal of) Provision for contingencies, net | (3,109 | ) | 1,360 | |
Interest accrued | 7,486 | 23,236 | ||
Other adjustments | 3,772 | 190,302 | ||
Change in operating assets and liabilities | (27,666 | ) | (34,281 | ) |
Trade and other receivables | 10,326 | (57,969 | ) | |
Tax receivables | (651 | ) | (1,718 | ) |
Prepaid expenses and other assets | 7,041 | (20,841 | ) | |
Account payables and accrued expenses | (59,389 | ) | 41,885 | |
Taxes payable | (2,817 | ) | 6,626 | |
Deferred consideration, contingent liabilities and others | 17,824 | (2,264 | ) | |
Cash used in operations | (113,305 | ) | (100,501 | ) |
Interest paid | (2,790 | ) | (33,895 | ) |
Net cash outflow from operating activities | (116,095 | ) | (134,396 | ) |
Purchase and development of intangible assets | (28,057 | ) | (23,919 | ) |
Acquisition of subsidiaries net of cash acquired | (24,386 | ) | (24,143 | ) |
Acquisitions of property and equipment | (175 | ) | (507 | ) |
Net cash outflow from investment activities | (52,618 | ) | (48,569 | ) |
Loans obtained | — | 122,015 | ||
Proceeds from exercise of stock options | 477 | 276 | ||
Acquisition of non-controlling interest | 5,018 | — | ||
Payment of loans | (28,416 | ) | (79,898 | ) |
Purchase of treasury shares | (34,542 | ) | — | |
Lease payments | (1,150 | ) | (870 | ) |
Proceeds from SPAC merger,net | — | 630,083 | ||
Net cash inflow (outflow) from financing activities | (58,613 | ) | 671,606 | |
Increase (decrease) in cash and cash equivalents | (227,326 | ) | 488,641 | |
Cash and cash equivalents at the beginning of the year | 338,020 | 52,149 | ||
Cash and cash equivalents at the end of the year | 111,434 | 532,416 | ||
Effect of exchange rate changes | 740 | (8,374 | ) | |
Increase (decrease) in cash and cash equivalents | (227,326 | ) | 488,641 |
Unaudited Consolidated Statement of Financial Position
(in BRL thousands)
ASSETS | ||||
Cash and cash equivalents | 111,434 | 338,020 | ||
Trade receivables and other, net | 128,876 | 139,546 | ||
Tax receivables | 11,968 | 11,317 | ||
Prepaid expenses and other assets | 24,411 | 35,060 | ||
PP&E, Intangible and right of use asset | 166,745 | 156,110 | ||
Deferred tax asset | 20,105 | 22,488 | ||
Total current assets | 270,702 | 519,169 | ||
Total non-current assets | 192,837 | 183,372 | ||
Total assets | 463,539 | 702,541 | ||
LIABILITIES | ||||
Loans and borrowings | 54,803 | 78,671 | ||
Trade and other payables | 48,782 | 107,695 | ||
Lease liabilities and other liabilities | 56,490 | 64,676 | ||
Taxes payable | 11,916 | 14,733 | ||
Derivatives financial instruments | 8,547 | 6,412 | ||
Deferred income tax | 6,517 | 8,929 | ||
Total current liabilities | 100,926 | 181,390 | ||
Total non-current liabilities | 86,129 | 99,726 | ||
Total liabilities | 187,055 | 281,116 | ||
EQUITY | ||||
Share capital | 425 | 425 | ||
Additional paid-in capital | 872,771 | 872,771 | ||
Capital reserves | 19,393 | 20,300 | ||
Other comprehensive income | (7,209 | ) | (6,840 | ) |
(31,904 | ) | (508 | ) | |
Accumulated loss | (580,267 | ) | (468,869 | ) |
Non-controlling interests | 3,275 | 4,146 | ||
Total equity | 276,484 | 421,425 | ||
Total equity + liabilities | 463,539 | 702,541 |
GAAP to Non-GAAP Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations and
(in BRL thousand)
Three Months Ended, |
Nine Months Ended, |
|||||||
2023 | 2022 | 2023 | 2022 | |||||
Loss for the period | (28,411 | ) | (199,520 | ) | (112,269 | ) | (285,670 | ) |
(+/-) Net interest income (expenses) | 1,661 | 2,456 | (8,815 | ) | 14,193 | |||
(+/-) Income tax | (358 | ) | (4,097 | ) | (112 | ) | (7,674 | ) |
(+) Depreciation and amortization | 7,591 | 4,943 | 23,755 | 12,420 | ||||
EBITDA | (19,516 | ) | (196,218 | ) | (97,441 | ) | (266,731 | ) |
(+) Share based plan expenses (1) | 26 | 1,098 | 2,200 | 4,005 | ||||
(+) Transaction expenses (2) | — | (8,224 | ) | — | 23,183 | |||
(+) Listing expenses (3) | — | 213,569 | — | 213,569 | ||||
(+) D&O Expenses (4) | 2,300 | 2 | 11,302 | 2 | ||||
(+/-) Fair Value of Derivative Financial Instruments (5) | (3,351 | ) | (16,883 | ) | 1,728 | (16,883 | ) | |
(+) Earn-Outs (6) | 3,474 | 500 | 7,026 | 500 | ||||
Adjusted EBITDA | (17,067 | ) | (6,156 | ) | (75,186 | ) | (42,355 | ) |
Net Revenue | 40,041 | 80,638 | 127,723 | 166,180 | ||||
Adjusted EBITDA Margin | (43)% | (8)% | (59)% | (25)% |
(1) Consists of expenses related to share based compensation grants, including payroll expenses in the amounts of
(2) Consists of concentrated expenses of an extraordinary nature related to third-party advisory, support services, travelling and events incurred in connection with our business combination with a SPAC that are not expected to be ongoing.
(3) Consists of a one-time non-cash expense reflecting the accounting impact of the NASDAQ listing in accordance with IFRS 2.
(4) Consists of expenses related to
(5) Consists of gains from fair value of Semantix Warrants.
(6) Consists of expenses related to earn-out payment to the former shareholders of Zetta and Elemeno.
(+) Cash and cash equivalents | 111,434 | 338,020 | ||
(-) Loans and borrowings | (54,803 | ) | (78,671 | ) |
(=) Total |
56,631 | 259,349 |
Investor Contact
Chief Financial Officer & IR
ir@semantix.ai
Press Contact
semantix@rpmacomunicacao.com.br
Source:

Source: Semantix, Inc.